Answers are grounded in this paper and cite their sources.
Yellow fever virus (YFV) is a mosquito-borne virus that causes an acute viral hemorrhagic disease in humans. The high morbidity, recurring large-scale outbreaks, vaccine shortages, and the absence of approved antiviral drugs continue to make YFV a major global health concern. Therefore, the development of safe and effective antiviral agents against YFV remains an urgent priority. In this study, we used a para-menthane monoterpenoid diol and various aldehydes to synthesize a broad series of heterocyclic compounds with hexahydro-2H-chromene and hexahydro-2H-4,6-(epoxymethane)chromene moieties. Evaluation of the antiviral activity of the synthesized compounds identified compound 8k bearing a the hexahydro-2H-4,6-(epoxymethano)chromene core as a potent novel inhibitor of YFV replication in vitro. Compound 8k significantly reduced extracellular viral RNA copies and infectious viral load, highlighting its potential as a promising lead for the development of novel anti-YFV therapeutics.
No takes yet. Share an insight, caveat, or question.
Ильина et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: